Literature DB >> 33384163

Comparisons of emotional health by diagnosis among women with early stage gynecological cancers.

Audrey Messelt1, Lauren Thomaier1, Patricia I Jewett2, Heewon Lee1, Deanna Teoh1, Susan A Everson-Rose3, Anne H Blaes2, Rachel I Vogel4.   

Abstract

OBJECTIVE: To assess self-reported emotional health in a cohort of women with early stage gynecologic cancers and to explore differences based on primary cancer type.
METHODS: We analyzed survey data from a cohort study of gynecological cancer patients treated at an academic cancer center. Measures of emotional health included cancer-related quality of life, distress, depression, anxiety, posttraumatic stress disorder (PTSD), and posttraumatic growth. Univariate and multivariate linear regression models examined differences in emotional health measures by primary cancer site. Potential confounders considered for inclusion in the final models were age, stage, education, income, partner status, treatment status, and race.
RESULTS: 242 patients with early stage disease completed the survey. Patients with cervical and vaginal/vulvar cancers reported greater cancer-related distress, anxiety and PTSD symptoms. Patients with endometrial cancer reported the lowest posttraumatic growth scores, which remained statistically significant after adjustment for demographic and clinical differences. No significant differences in cancer-related quality of life were observed among individuals with different primary cancer sites
CONCLUSIONS: These data suggest patients with early-stage gynecologic cancer face different psychosocial sequelae based on primary cancer site, though underlying clinical and sociodemographic factors may play a significant role in this observed relationship. Further research is needed to assess poorer emotional health among individuals with vaginal/vulvar cancers and the lower posttraumatic growth among patients with endometrial cancer as posttraumatic growth is considered a potentially beneficial psychosocial outcome of cancer.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2020        PMID: 33384163      PMCID: PMC7902419          DOI: 10.1016/j.ygyno.2020.12.019

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  34 in total

1.  Anxiety and depression after cancer diagnosis: prevalence rates by cancer type, gender, and age.

Authors:  Wolfgang Linden; Andrea Vodermaier; Regina Mackenzie; Duncan Greig
Journal:  J Affect Disord       Date:  2012-06-21       Impact factor: 4.839

Review 2.  Efficacy and medical cost offset of psychosocial interventions in cancer care: making the case for economic analyses.

Authors:  Linda E Carlson; Barry D Bultz
Journal:  Psychooncology       Date:  2004-12       Impact factor: 3.894

Review 3.  A brief review of the management of platinum-resistant-platinum-refractory ovarian cancer.

Authors:  Bryan Oronsky; Carolyn M Ray; Alexander I Spira; Jane B Trepel; Corey A Carter; Hope M Cottrill
Journal:  Med Oncol       Date:  2017-04-25       Impact factor: 3.064

Review 4.  Aloneness: the lived experience of women with cancer of the vulva.

Authors:  H Jefferies; C Clifford
Journal:  Eur J Cancer Care (Engl)       Date:  2011-04-11       Impact factor: 2.520

5.  Lower preoperative quality of life increases postoperative risk of adverse events in women with endometrial cancer: results from the LACE trial.

Authors:  Jannah Baker; Monika Janda; Val Gebski; Peta Forder; Russell Hogg; Tom Manolitsas; Andreas Obermair
Journal:  Gynecol Oncol       Date:  2015-02-14       Impact factor: 5.482

6.  Attributions, beliefs about control, and adjustment to breast cancer.

Authors:  S E Taylor; R R Lichtman; J V Wood
Journal:  J Pers Soc Psychol       Date:  1984-03

7.  Quality of life and mood in women receiving extensive chemotherapy for gynecologic cancer.

Authors:  S K Lutgendorf; B Anderson; N Rothrock; R E Buller; A K Sood; J I Sorosky
Journal:  Cancer       Date:  2000-09-15       Impact factor: 6.860

Review 8.  Assessment and significance of quality of life in women with gynecologic cancer.

Authors:  Dana M Chase; Tawny Watanabe; Bradley J Monk
Journal:  Future Oncol       Date:  2010-08       Impact factor: 3.404

9.  Quality of life of women with ovarian cancer.

Authors:  A B Kornblith; H T Thaler; G Wong; V Vlamis; J M Lepore; D B Loseth; T Hakes; W J Hoskins; R K Portenoy
Journal:  Gynecol Oncol       Date:  1995-11       Impact factor: 5.482

10.  Assessment of the Quality of Life for Gynecologic Cancer Patients Using Functional Assessment of Cancer Therapy-General (Fact-G) Questionnaire at Haji Adam Malik Hospital.

Authors:  Deri Edianto; Muhammad Rizki Yaznil; Ade Ayu Chartyansari; Iman Helmi Effendi
Journal:  Open Access Maced J Med Sci       Date:  2019-07-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.